Select a community
MS
Find out more about the PatientsLikeMe
MS Community
Home > Community Treatment Reports > Copaxone (glatiramer acetate) Treatment Report
What is Copaxone?

Copaxone®, a brand name for glatiramer acetate, combines four amino acids including L-alanine, L-glutamic acid, L-lysine and L-tyrosine. It is used for Relapsing-Remitting Multiple Sclerosis (RRMS) to reduce the frequency and severity of relapses. It is administered as a subcutaneous injection.

Side Effects

Side effects as an overall problem

Severe
39 9%
Moderate
70 16%
Mild
223 50%
None
118 26%

Most commonly reported side effects

lumps
241 54%
Injection site reaction
209 46%
redness
199 44%
Injection site itching
189 42%
Injection site pain
170 38%
Bruising
131 29%
  • Mild
  • Moderate
  • Severe

Dosages

Top 10 dosages based on patients currently taking Copaxone. See all 37 dosages ►

  20mg as needed 20mg/mL as needed 20mg weekly daily 1 mL weekly 0.2 mg daily 1 daily 1 g daily 1 mg daily 1 mL daily 2 mg daily 20 mg weekly 5 mg daily 40 mg weekly 10 mg daily 20 mg 20 mg every other day 13 mg daily 15 mg daily 20 daily 20 mcg daily 20 mg daily 22 mg daily 25 mg daily 30 mg daily 40 mg daily 44 mg daily 50 mg daily 60 mg daily 80 mg daily 81 mg daily 100 mg daily 120 mg daily 200 mg daily 250 mg daily 300 mg daily 1200 mg daily
  2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 240 Number of Patients: 240 1 Number of Patients: 1 1 Number of Patients: 1 6 Number of Patients: 6 1 Number of Patients: 1 42 Number of Patients: 42 4 Number of Patients: 4 2 Number of Patients: 2 3 Number of Patients: 3 2 Number of Patients: 2 1 Number of Patients: 1 12 Number of Patients: 12 1 Number of Patients: 1 27 Number of Patients: 27 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1425 Number of Patients: 1425 1 Number of Patients: 1 5 Number of Patients: 5 7 Number of Patients: 7 6 Number of Patients: 6 3 Number of Patients: 3 3 Number of Patients: 3 6 Number of Patients: 6 1 Number of Patients: 1 1 Number of Patients: 1 3 Number of Patients: 3 1 Number of Patients: 1 9 Number of Patients: 9 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1  

Stop Reasons

Why Patients Stopped Taking Copaxone (multiple reasons could be selected)
Reason # Patients Percentage of patients
Did not seem to work
257 39% Did not seem to work: 39%
Side effects too severe
223 33% Side effects too severe: 33%
Doctor's advice
167 25% Doctor's advice: 25%
Other
133 20% Other: 20%
Expense
51 8% Expense: 8%
Personal research
28 4% Personal research: 4%
Not indicated
11 2% Not indicated: 2%
Course of treatment ended
7 1% Course of treatment ended: 1%

See all 643 patients who’ve stopped taking Copaxone

Duration See details about how long patients take this treatment ▼

Currently Taking Copaxone

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
9
36
75
175
196
369

Stopped Taking Copaxone

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
31
57
90
131
125
198

Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Always
347 77%
Usually
80 18%
Sometimes
17 4%
Never
6 1%

Burden

Difficulty being on treatment

Very
39 9%
Somewhat
93 21%
A little
194 43%
Not at all
124 28%

Cost

Paid out of pocket

$200+
42 9%
$100-199
15 3%
$50-99
30 7%
$25-49
80 18%
< $25
169 38%

See more information, including instructions, precautions, side effects, and interactions.

Report created on November 21, 2009.